申请人:Crawford B. Jason
公开号:US20050209277A1
公开(公告)日:2005-09-22
This invention relates to a process for synthesizing heterocyclic pharmaceutical compound which binds to the CXCR4 chemokine receptor. In one embodiment, the process comprises: a) reacting a 5,6,7,8-tetrahydroquinolinylamine and an alkyl aldehyde bearing a phthalimide or a di-tertiary-butoxycarbonyl (di-BOC) protecting group to form an imine; b) reducing the imine to form a secondary amine; c) reacting the secondary amine with a haloalkyl substituted heterocyclic compound, to form a phthalimido-protected or di-tert-butoxycarbonyl protected tertiary amine; and d) hydrolyzing the protected amine to obtain a compound having Formula I′
本发明涉及一种合成与CXCR4趋化因子受体结合的杂环药物化合物的方法。在一种实施方式中,该方法包括:a)反应5,6,7,8-四氢喹啉基胺和带有邻苯二甲酰亚胺或双叔丁基氧羰基(双-BOC)保护基的烷基醛,形成亚胺;b)还原亚胺,形成二级胺;c)将二级胺与卤代烷基取代的杂环化合物反应,形成邻苯二甲酰亚胺保护或双叔丁基氧羰基保护的三级胺;d)水解保护胺,得到具有I'式的化合物。